Psychosis Clinical & Research Program
Contact Information
Psychosis Clinical & Research Program (PCRP)
151 Merrimac St, Suite 401
Boston,
MA
02114
Phone: 617-643-1175
Fax: 617-643-1331
The MGH Psychosis Clinical and Research (PCRP) Summer Internship provides an opportunity for undergraduate students to gain hands-on experiences in both the clinical care of people with a serious mental illness, particularly psychosis/schizophrenia and clinical/translational research.
Learn more
Explore This Program
About Us
The Massachusetts General Hospital Psychosis Clinical and Research Program (PCRP), co-led by Drs. Oliver Freudenreich and Daphne Holt, seeks to improve the quality of life for people with psychosis or schizophrenia by reducing distressing psychotic symptoms, improving function in school, work and relationships and promoting better physical health. The team of clinicians and researchers also conducts state-of-the-art research that focuses on medication intervention trials, neuroscience and brain imaging, genetics and psychosocial interventions. At the PCRP, we offer comprehensive diagnostic evaluations, second opinion consultations, a clozapine clinic and ongoing treatment for adolescent and adult patients with psychosis, including conditions such as schizophrenia and related disorders.
The PCRP is part of the Massachusetts General Hospital Department of Psychiatry. The Mass General Department of Psychiatry is ranked #1 by US News and World Report and has consistently earned top rankings in psychiatry for its exceptional patient care every year since 1996.
Clinical Services
The PCRP clinical program is composed of four services: the First Episode and Early Psychosis Program (FEPP), the Recovery and Ongoing Care Clinic (ROCC), a Clozapine Clinic and the Psychosis Consultation Service.
In addition, the PCRP collaborates with the Resilience and Prevention Program to oversee the Resilience Evaluation-Social Emotional Training (RE-SET) Program, a clinical service for adolescents and young adults (ages 12-30) who are experiencing changes in their thoughts, feelings, behaviors and may not be functioning as well as they used to. Young people with these symptoms may be at risk for developing psychosis or another neuropsychiatric condition and thus RE-SET offers eligible individuals a comprehensive evaluation, and recommendations for additional assessments, monitoring and/or care.
First-Episode and Early Psychosis Program (FEPP)
The First-Episode and Early Psychosis Program (FEPP) offers highly specialized evaluation, treatment and education for people who are experiencing psychosis for the first time.
The FEPP evaluates and treats people who:
- Are experiencing psychosis for the first time
- Are between the ages of 14 and 35
- Are residents of Greater Boston
- Our program offers:
- Medical and psychological evaluation
- Diagnostic second opinion consultations
- Medication treatment
- Education and family support
- Cognitive behavioral therapy, a form of talk therapy
Screening process: If you are interested in treatment at the FEPP, please click on the link below for the referral form. The form can be filled out by the patient, family member, or provider.
https://redcap.link/referralPCRP
The screening process may take time, and you may be contacted for additional information as all referrals are screened for clinical appropriateness. Submitting the referral is not a guarantee of treatment.
During your initial visit, you will meet with a member of our clinical team. The clinical team member will ask you questions about your mental health, medications and medical history and we will determine what treatment program will best meet your needs. You may be offered ongoing treatment through the FEPP or you may be directed to other appropriate treatment options. An initial visit is not a guarantee of ongoing treatment.
Program Duration: If you enter the program, program participation is limited to two years. At that point, we will evaluate your need for continued treatment and can assist with a transition to appropriate care.
Recovery and Ongoing Care Clinic (ROCC)
The Recovery and Ongoing Care Clinic (ROCC) at Massachusetts General Hospital evaluates and provides psychiatric medication treatment to people with ongoing psychotic illness who:
- Have received a diagnosis of a psychotic disorder (such as schizophrenia or schizoaffective disorder) more than 5 years ago
- Are adults (18 or older)
- Are residents of Greater Boston
ROCC is appropriate for patients who are stable on currently effective medications, as well as those who have not yet found an effective medication and would like to try new treatments. At this time, psychotherapy and case management are not available through ROCC. Note that this program primarily serves former patients of FEPP (i.e., FEPP “graduates”) who no longer require the intensive coordinated specialty care that FEPP provides but need to receive their medical care at MGH.
Screening process:
If you are interested in treatment at the ROCC, please click on the link below for the referral form. The form can be filled out by patients, family members, or providers.
https://redcap.link/referralPCRP
The screening process may take time, and you may be contacted for additional information as all referrals are screened for clinical appropriateness. Submitting the referral is not a guarantee of treatment.
Clozapine Clinic
The Clozapine Clinic at Massachusetts General Hospital evaluates and provides psychiatric medication treatment to people with psychotic illness who:
- Are adults (18 or older)
- Are residents of Greater Boston
- Are taking the antipsychotic clozapine or are interested in a clozapine trial
Clozapine is the most effective antipsychotic medication, and timely consideration of clozapine treatment can be lifesaving. Clozapine should be tried as soon as treatment-resistance is apparent which may be within 4 to 6 months of unsuccessful, sequential treatment with two other antipsychotics. Administering and managing clozapine safely requires expertise, and clinicians in the MGH Clozapine Clinic have years of expertise in successfully administering clozapine. The MGH Clozapine Clinic also serves as a headquarters for providing centralized guidance and support to clozapine prescribers nationwide.
If you are interested in treatment at the Clozapine Clinic, please click on the link below for the referral form. The form can be filled out by patients, family members, or providers.
https://redcap.link/referralPCRP
The screening process may take time, and you may be contacted for additional information as all referrals are screened for clinical appropriateness. Submitting the referral is not a guarantee of treatment. Submitting the referral is not a guarantee of treatment. In some cases, we may recommend a referral to our community partner, North Suffolk Mental Health Association, with whom we have a clozapine collaborative relationship.
Psychosis Consultation Service
We provide clinical expertise and guidance to MGH clinicians and the larger psychiatric community for their patients who have not adequately responded to treatment or for those who are seeking diagnostic clarification.
Psychiatric providers: If you are interested in a one-time consultation, please click on the link below for the consult referral form.
https://redcap.link/referralPCRPconsults
Patients and family members: If you are interested in a consultation, please discuss this with your treating clinician. The referral form must be filled out by the current prescribing provider.
The screening process may take time, and you may be contacted for additional information as requests are screened for clinical appropriateness. Submitting a request is not a guarantee of consultation appointment. Note that patients seen in the Psychosis Consultation Service will not become patients of the Psychosis Clinical and Research Program and no responsibility for their treatment is assumed. All responsibility for ongoing treatment remains with the current clinicians, including arranging for any further treatments or tests that are recommended.
Additional Resource: How to Get an Appointment with a Psychiatrist
Our healthcare system is fragmented, and the mental healthcare system is stretched thin, with too few psychiatrists. This can make it challenging to access mental health services, so don’t give up after your first try didn’t work.
If you need help with a psychiatric emergency, go to your nearest emergency room or call 911. Do not go to an emergency room to simply get a referral for outpatient care. Emergency rooms are completely overwhelmed during the pandemic.
Here are a few steps to try if you are looking for a psychiatrist:
- Contact your PCP (often the best first step)
PCPs often have access to a network of mental health providers to whom they can refer you. In addition, many psychiatrists in larger healthcare systems can only see you if you have a PCP in that healthcare system. You may need to sign up for a PCP in that system. For example, a psychiatrist at MGH can only see you if you have an MGH PCP. If you do not have a PCP, you can call your insurance company (look for the main number of the back of your insurance card) and ask for a list of PCPs who are accepting new patients.
- Contact your university student health service (good step if you are part of a university)
If you are connected to a university (e.g., if you are a student) contact your university’s medical service.
- Contact your insurance
Insurances in theory have a list of contracted healthcare providers. However, their lists are often not up-to-date, and even if you are given an accurate list, you are still left with making phone calls to individual providers or clinics. If you do get a list, you may want to call many providers on it to increase your chances of making a successful connection (some providers may not be taking new patients, some may have moved or retired).
- Contact a university’s outpatient department of psychiatry
Phone numbers for appointments are usually easy to find using the hospital’s website. However, wait lists are usually very long and insurance issues (among others) may prevent you from receiving care. In some cases, contacting a specialty service directly (if you know your diagnosis) may work.
- Example for a university specialty service:
- MGH Psychosis Clinical and Research Program. This program specializes in the care of people with psychosis (schizophrenia or severe bipolar disorder). Call the clinic at 617-643-1175 to find out if you are eligible for care.
- Contact independent psychiatric care providers (good if you know your diagnosis)
This can be an individual practitioner in private practice or an outpatient psychiatric clinic (community mental health clinic).
Wait lists and insurance issues (ability to pay if private) may get in the way of receiving care. Most psychiatrists in private practice do not accept insurance. Outpatient psychiatric clinics are sometimes called community mental health centers. Typically, you need to see a social worker first for an “intake” before you can see a psychiatrist. Outpatient clinics locations and contact information can be identified through an internet search.
- Example for a community mental health provider:
- North Suffolk Mental Health Association (NSMHA). This organization runs several clinics including the Freedom Trail Clinic (FTC) in downtown Boston. Appointments at FTC can be arranged by calling 617-912-7800. The NSMHA website is https://northsuffolk.org/
- Contact your local Emergency Services Program (ESP)
Every city or town in Massachusetts has a designated emergency services program (ESP) whose role is to manage mental health treatment for the community. While ESPs focus largely on people with Medicaid or those who have no health insurance, they can also be more generally helpful in suggesting ways to access care, regardless of insurance type. A list of ESPs by town can be found here: https://www.mass.gov/info-details/emergency-services-program-contact-information
- Example for an ESP:
- Boston Emergency Services Team (BEST): BEST is the ESP for people who live in Boston, Cambridge and Somerville. Despite their name, they may be able to review your case and guide you about what to do next, even if it is not an emergency. The Boston team can also help you find your local team. The phone number for BEST is 800-981-4357. Their website is https://northsuffolk.org/services/emergency-services/boston-emergency-services-team/
- Contact the NAMI Compass Helpline
The National Alliance on Mental Illness (NAMI) Compass Helpline can provide information about how to access mental health treatment in Massachusetts. Their phone numbers are 617-704-6264 or 800-370-9085. Their email is compass@namimass.org. Their website is https://namimass.org/nami-mass-compass-helpline/
Other Community Resources
The Freedom Trail Clinic (FTC) - For more than 30 years, the Massachusetts General Hospital's Psychosis Clinical and Research Program has worked with a strong community partner, North Suffolk Mental Health Association, which provides community-based care for psychiatric patients, including those with schizophrenia and other psychotic disorders and those who require clozapine treatment or long-acting injectable antipsychotics. Please contact the Freedom Trail Clinic at 617-912-7800 for more information about their clinical program.
Insurances We Accept
This program does not accept all insurances. Please call your insurance company to learn if you have benefits to be seen by Mass General Physicians Organization Psychiatry. We bill as a group, not as individual providers.
Please visit MGH Psychiatry FAQ's to learn more about insurances we do not accept.
Research at the PCRP
World-class researchers and caregivers work together in the Psychosis Clinical and Research Program to deepen our understanding of risk factors of psychosis, full course of schizophrenia and other related disorders and to translate that understanding into compassionate, cutting-edge effective treatment for our patients. What makes our team unique is that many of our researchers are also clinicians who see patients.
Areas of Research
- Emotion and Social Neuroscience Lab (ESNL), led by Dr. Daphne Holt, studies abnormalities in emotion and social cognition in individuals with psychosis and related conditions, as well as in young adults and adolescents at risk for developing psychopathology. ESNL uses a multimodal approach, including behavioral, physiological, and neuroimaging methods, to investigate questions about the neurobehavioral mechanisms of the core symptoms of psychosis and other serious mental illnesses.
- The Resilience and Prevention Program (RAPP), led by Dr. Daphne Holt, tests whether teaching certain techniques associated with resilience may be protective for at-risk individuals and play a role in the prevention of serious mental illness.
- The Intervention Clinical Trials Program research team seeks better medication options to treat schizophrenia symptoms and mitigate the medical problems associated with existing medications.
- Early Brain Development Institute, led by Dr. Joshua Roffman aims to discover, develop, and implement prenatal and early life interventions to prevent neuropsychiatric illness, especially among children who are at increased risk for these disorders.
- Sleep, Cognition and Neuropsychiatry Lab (SCAN), led by Dr. Dara Manoach, presently investigates the contribution of abnormal sleep to cognitive deficits in schizophrenia.
- Center of Excellence (COE) for Psychosocial and Systemic Research aims to improve the lives of people with mental health challenges through projects focused on physical, emotional, and social aspects of health.
Active Studies
Meet Our Team
The Psychosis Clinical & Research Program includes a team of expert clinicians who offer comprehensive diagnostic evaluations, second opinion consultations and ongoing treatment for patients with schizophrenia.
-
- Co-Director, MGH Psychosis Clinical and Research Program
- Director, MGH Fellowship in Public and Community Psychiatry
-
- Co-Director, Mass General Psychosis Clinical and Research Program
-
- Director of Child Psychiatry Emergency Services
- Director of Clinical Services, Psychosis Clinical and Research Program
- Associate Director, Acute Psychiatry Service
-
- Director, MGH Center of Excellence for Psychosocial and Systemic Research
- Associate Professor, Harvard Medical School
-
- Co-Director, Mass General Neuroscience
- Director, Mass General Early Brain Development Initiative
- Associate Professor of Psychiatry, Harvard Medical School
Meet the full team
- Baktash Babadi, MD, PhD
- Jacqueline Clauss, MD, PhD
- Drew Coman, PhD
- Nicole DeTore, PhD
- Hamdi Eryilmaz, PhD
- A Eden Evins, PhD
- Cheryl Foo, PhD
- Victoria Hasler, PhD
- Marta Hernandez (administrative coordinator)
- Martha Humphreys (supported education & employment specialist)
- Kelly Irwin, MD
- Gina Kuperberg, MD, PhD
- Carol Lim, MD
- Desta Lissanu, MD
- Dara Manoach, PhD
- Sarah MacLaurin, PMHNP
- Dimitrios Mylonas, PhD
- Shreedhar Paudel, MD, MPH
- Katelyn Ragone (pre-doctoral student)
- Faith Scanlon, PhD (post-doctoral clinical research fellow)
- John Tyson, MD
- Lauren Utter, PsyD
- Alexandra Volpacchio, PsyD
Patient Education & Resources
Schizophrenia and Psychosis are serious, but also misunderstood, conditions. If you think a loved one is dealing with psychosis, it’s vital to get help in the early stages of the illness. Begin by learning more about schizophrenia and other forms of psychosis.
Support Our Work
At Mass General, families are our highest priority. We partner with our patients to provide high-quality specialty care, tailored to meet each family’s preferences and health care needs. Your support helps us get families off to a healthy start.
#1 in Psychiatry
U.S. News & World Report rates Mass General Psychiatry the top in the nation.
Department of Psychiatry
For 80 years, Mass General's Psychiatry Department has provided the highest quality patient care through pioneering research.
Pioneering Neuroscience Research
As a world leader in medical discovery and patient care, Mass General Neuroscience brings together the expansive expertise and passion from our Psychiatry, Neurosurgery and Neurology Departments. Through Advances in Motion, we provide health care professionals with information about our latest breakthroughs, research and clinical advances.